Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Autor: Jiang, Yu, Meyers, Travis J., Emeka, Adaeze A., Cooley, Lauren Folgosa, Cooper, Phillip R., Lancki, Nicola, Helenowski, Irene, Kachuri, Linda, Lin, Daniel W., Stanford, Janet L., Newcomb, Lisa F., Kolb, Suzanne, Finelli, Antonio, Fleshner, Neil E., Komisarenko, Maria, Eastham, James A., Ehdaie, Behfar, Benfante, Nicole, Logothetis, Christopher J., Gregg, Justin R., Perez, Cherie A., Garza, Sergio, Kim, Jeri, Marks, Leonard S., Delfin, Merdie, Barsa, Danielle, Vesprini, Danny, Klotz, Laurence H., Loblaw, Andrew, Mamedov, Alexandre, Goldenberg, S. Larry, Higano, Celestia S., Spillane, Maria, Wu, Eugenia, Carter, H. Ballentine, Pavlovich, Christian P., Mamawala, Mufaddal, Landis, Tricia, Carroll, Peter R., Chan, June M., Cooperberg, Matthew R., Cowan, Janet E., Morgan, Todd M., Siddiqui, Javed, Martin, Rabia, Klein, Eric A., Brittain, Karen, Gotwald, Paige, Barocas, Daniel A., Dallmer, Jeremiah R., Gordetsky, Jennifer B., Steele, Pam, Kundu, Shilajit D., Stockdale, Jazmine, Roobol, Monique J., Venderbos, Lionne D.F., Sanda, Martin G., Arnold, Rebecca, Patil, Dattatraya, Evans, Christopher P., Dall’Era, Marc A., Vij, Anjali, Costello, Anthony J., Chow, Ken, Corcoran, Niall M., Rais-Bahrami, Soroush, Phares, Courtney, Scherr, Douglas S., Flynn, Thomas, Karnes, R. Jeffrey, Koch, Michael, Dhondt, Courtney Rose, Nelson, Joel B., McBride, Dawn, Cookson, Michael S., Stratton, Kelly L., Farriester, Stephen, Hemken, Erin, Stadler, Walter M., Pera, Tuula, Banionyte, Deimante, Bianco, Fernando J., Jr., Lopez, Isabel H., Loeb, Stacy, Taneja, Samir S., Byrne, Nataliya, Amling, Christopher L., Martinez, Ann, Boileau, Luc, Gaylis, Franklin D., Petkewicz, Jacqueline, Kirwen, Nicholas, Helfand, Brian T., Xu, Jianfeng, Scholtens, Denise M., Catalona, William J., Witte, John S.

Publikováno v: In Human Genetics and Genomics Advances 13 January 2022 3(1)

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Autor: Yu Jiang, Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki, Irene Helenowski, Linda Kachuri, Daniel W. Lin, Janet L. Stanford, Lisa F. Newcomb, Suzanne Kolb, Antonio Finelli, Neil E. Fleshner, Maria Komisarenko, James A. Eastham, Behfar Ehdaie, Nicole Benfante, Christopher J. Logothetis, Justin R. Gregg, Cherie A. Perez, Sergio Garza, Jeri Kim, Leonard S. Marks, Merdie Delfin, Danielle Barsa, Danny Vesprini, Laurence H. Klotz, Andrew Loblaw, Alexandre Mamedov, S. Larry Goldenberg, Celestia S. Higano, Maria Spillane, Eugenia Wu, H. Ballentine Carter, Christian P. Pavlovich, Mufaddal Mamawala, Tricia Landis, Peter R. Carroll, June M. Chan, Matthew R. Cooperberg, Janet E. Cowan, Todd M. Morgan, Javed Siddiqui, Rabia Martin, Eric A. Klein, Karen Brittain, Paige Gotwald, Daniel A. Barocas, Jeremiah R. Dallmer, Jennifer B. Gordetsky, Pam Steele, Shilajit D. Kundu, Jazmine Stockdale, Monique J. Roobol, Lionne D.F. Venderbos, Martin G. Sanda, Rebecca Arnold, Dattatraya Patil, Christopher P. Evans, Marc A. Dall’Era, Anjali Vij, Anthony J. Costello, Ken Chow, Niall M. Corcoran, Soroush Rais-Bahrami, Courtney Phares, Douglas S. Scherr, Thomas Flynn, R. Jeffrey Karnes, Michael Koch, Courtney Rose Dhondt, Joel B. Nelson, Dawn McBride, Michael S. Cookson, Kelly L. Stratton, Stephen Farriester, Erin Hemken, Walter M. Stadler, Tuula Pera, Deimante Banionyte, Fernando J. Bianco, Jr., Isabel H. Lopez, Stacy Loeb, Samir S. Taneja, Nataliya Byrne, Christopher L. Amling, Ann Martinez, Luc Boileau, Franklin D. Gaylis, Jacqueline Petkewicz, Nicholas Kirwen, Brian T. Helfand, Jianfeng Xu, Denise M. Scholtens, William J. Catalona, John S. Witte

Publikováno v: HGG Advances, Vol 3, Iss 1, Pp 100070- (2022)

Summary: Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for PC, many men on AS eventually convert to active

Externí odkaz: https://doaj.org/article/dd671a3166f5492e9f3db2429cd59265

Anger and intertemporal choice: The behavioral approach system and the interactive effects of trait and state anger

Autor: Zhao, Jinling, Kirwen, Nicholas, Johnson, Jedidiah, Vigo, Ronaldo

Publikováno v: In Personality and Individual Differences 1 May 2017 110:60-64

2,3-Diaryl-3H-imidazo[4,5-b]pyridine derivatives as potential anticancer and anti-inflammatory agents

Autor: Erin Marie Kirwen, Tarun Batra, Chandrabose Karthikeyan, Girdhar Singh Deora, Vandana Rathore, Chaitanya Mulakayala, Naveen Mulakayala, Amy Catherine Nusbaum, Joel Chen, Haneen Amawi, Kyle McIntosh, Sahabjada, Neelam Shivnath, Deepak Chowarsia, Nisha Sharma, Md Arshad, Piyush Trivedi, Amit K. Tiwari

Publikováno v: Acta Pharmaceutica Sinica B, Vol 7, Iss 1, Pp 73-79 (2017)

In this study we examined the suitability of the 3H-imidazo[4,5-b]pyridine ring system in developing novel anticancer and anti-inflammatory agents incorporating a diaryl pharmacophore. Eight 2,3-diaryl-3H-imidazo[4,5-b]pyridine derivatives retrieved

Externí odkaz: https://doaj.org/article/24a5aeeee05a48328aedbe8d44d089cf

NMDA-R ENCEPHALITIS: TALE OF TWO TESTS: SERUM NEGATIVE, CSF POSITIVE

Autor: Sanjay Dogra, Jessica Kuxhause, Abdulgadir K. Adam, Tanaz Salimnia, Devika Aggarwal, Suleiman Kojan, Rameen Ghandchi, Abagail Kirwen, Michael Sobin, Adrian Michel, Raashi Chawla

Publikováno v: Chest. 160:A1112-A1113

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb832ec4caf0014a8179838495027473
https://doi.org/10.1016/j.chest.2021.07.1023